This Week in Science

A team from Brandeis University reports in Science this week on the discovery of a handful of ancient genetic mutations that are responsible for the activity of the cancer drug Gleevec against tumors expressing one type of oncogene, but not a related one. Gleevec works by blocking the activity of Abl tyrosine kinase, but is ineffective against closely homologous tyrosine kinases such as Src.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.